Detachable String Magnetically Controlled Capsule Endoscopy for Detecting High-risk Varices in Compensated Cirrhosis

NCT03749954 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2020-11-17

No results posted yet for this study

Summary

Gastroesophageal varices is a serious complication of compensated advanced chronic liver disease (cACLD). Primary prophylaxis to reduce the risk of variceal haemorrhage is recommended if high-risk varices (HRV) are detected. We performed this study to compare the accuracy, patients' satisfaction and safety of detection of HRV by detachable string magnetically controlled capsule endoscopy (DS-MCCE) with esophagogastroduodenoscopy (EGD) as the standard.

Conditions

  • Compensated Cirrhosis
  • Gastroesophageal Varices Bleeding

Interventions

DIAGNOSTIC_TEST

Detachable string magnetically controlled capsule endoscopy

Esophagogastroduodenoscopy is performed 2 hours after the magnetically controlled capsule endoscopy (Ankon Medical Technologies Co. Ltd.).

Sponsors & Collaborators

  • Beijing 302 Hospital

    collaborator OTHER
  • Sir Run Run Shaw Hospital

    collaborator OTHER
  • Zhujiang Hospital

    collaborator OTHER
  • Shandong Provincial Hospital

    collaborator OTHER_GOV
  • Shanghai Tongji Hospital, Tongji University School of Medicine

    collaborator OTHER
  • Third Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • Guangdong Second Provincial General Hospital

    collaborator OTHER
  • The Fifth Affiliated Hospital of Zunyi Medical College

    collaborator OTHER
  • LanZhou University

    collaborator OTHER
  • Sheffield Teaching Hospitals NHS Foundation Trust

    collaborator OTHER
  • Changhai Hospital

    collaborator OTHER
  • The Second Affiliated Hospital of Baotou Medical College

    collaborator OTHER
  • Nanfang Hospital, Southern Medical University

    lead OTHER

Principal Investigators

  • Xiaolong Qi, M.D. · LanZhou University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-09
Primary Completion
2019-12-03
Completion
2022-11-08

Countries

  • China
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03749954 on ClinicalTrials.gov